Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cognition Therapeutics Inc (CGTX)

Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cognition Therapeutics Inc 2500 WESTCHESTER AVENUE PURCHASE NY 10577 USA

www.cogrx.com Employees: 28 P: 412-481-2210

Sector:

Medical

Description:

Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.

Key Statistics

Overview:

Market Capitalization, $K 125,349
Enterprise Value, $K 100,339
Shares Outstanding, K 88,274
Float, K 75,563
% Float 85.60%
Short Interest, K 5,791
Short Float 6.56%
Days to Cover 6.09
Short Volume Ratio 0.28
% of Insider Shareholders 14.40%
% of Institutional Shareholders 43.35%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -33,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,930 K
EBIT, $ -44,860 K
EBITDA, $ -44,590 K

Growth:

1-Year Return 89.78%
3-Year Return -27.72%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/06/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -0.48
EPS Growth vs. Prev Qtr 45.45%
EPS Growth vs. Prev Year 76.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CGTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -150.10%
Return-on-Assets % -95.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.82
Book Value/Share 0.50
Interest Coverage -1,131.33
60-Month Beta 1.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar